Dare Bioscience, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration
Dare Bioscience, Inc. (DARE) had Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration of $1.10 million as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Alternative
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration · last filed 2025-03-31
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $1.10M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $1.20M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $900.00K.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $200.00K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration |
|---|---|
| 2024-12-31 | $1.10M 10-K · filed 2025-03-31 |
| 2023-12-31 | $1.20M 10-K · filed 2024-03-28 |
| 2022-12-31 | $900.00K 10-K · filed 2023-03-30 |
| 2021-12-31 | $200.00K 10-K · filed 2022-03-31 |
| 2020-12-31 | $200.00K 10-K · filed 2021-03-30 |
| 2019-12-31 | $135.00M 10-K · filed 2020-03-27 |
| 2018-12-31 | $135.00M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |